News

In January 2022 marketing authorization was received in Moldova for Airing™. Airing™ has been licensed from Mithra (Belgium) and is a generic version of Nuvaring™, a hormonal contraceptive vaginal ring. Market introduction is expected for the second half of 2023. Marketing authorization in Ukraine is

In November and December 2021, marketing authorizations were received in respectively Moldova and Bulgaria for Aivial™. Aivial™ has been licensed from Mithra (Belgium) and is widely prescribed for treating menopausal syndromes. Market introductions are expected in the second half of 2023. The marketing authorization for

Liege, Belgium, 24 October 2019 – 7 :30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it has entered into two exclusive license and supply agreements with Aicore Life Sciences for the registration and commercialization of two major

New interim results confirm the findings of February this year Lactate Ring (an Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release) is a vaginal ring matrix system consisting of a mixture of ethylene vinyl acetate and methacrylic acid-methyl methacrylate copolymer loaded with 150 mg DL-lactic

Interim results of the clinical trial (“proof of concept”) for the vaginal ring containing lactic acid as an active ingredient are positive. The trial started in the fourth quarter of 2018. Final results are expected in the third quarter of 2019. This new product will

An agreement was signed between the University of Ghent and Aicore Life Sciences (ALS) for the further development of a new dosage form (vaginal ring) containing lactic acid for the treatment of (recurrent) bacterial vaginosis. The University of Ghent owns the fundamental rights to this

A Letter of the Internet was signed between Aicore Life Sciences’ “founding” fathers (CLS-Ukraine, Aicore and Dr. PG Ruifrok) to establish the incorporation of a new pharmaceutical company registered in The Netherlands. The company will own product dossiers, trademarks and other Intellectual Property Rights for